Perimeter Medical Imaging AI Reports Strong 2024 Growth and Advances B-Series OCT Development

Perimeter Medical Imaging AI ( (TSE:PINK) ) has issued an update.

Perimeter Medical Imaging AI reported significant financial growth in 2024, with a 303% increase in Q4 revenues compared to the previous year, driven by the adoption of its S-Series OCT systems. The company is advancing its B-Series OCT system, having successfully completed a pivotal trial for breast-conserving surgeries and submitted a PMA application to the FDA. This progress positions Perimeter for further expansion and potential regulatory approval, which could enhance its market position and impact stakeholders positively.

More about Perimeter Medical Imaging AI

Perimeter Medical Imaging AI, Inc. is a commercial-stage medical technology company operating in the healthcare industry. The company focuses on developing advanced imaging technologies, particularly optical coherence tomography (OCT) systems, to aid in surgical procedures. Their primary products include the FDA-cleared Perimeter S-Series OCT and the next-generation Perimeter B-Series OCT, which integrates AI technology for enhanced imaging capabilities. The company is actively expanding its market presence in the United States.

YTD Price Performance: 33.33%

Average Trading Volume: 82,112

Technical Sentiment Signal: Buy

Current Market Cap: C$53.1M

See more data about PINK stock on TipRanks’ Stock Analysis page.